Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0538-2023

Drug recall · April 26, 2023

C-Semaglutide 5mg/mL injection recall

Why: Lack of assurance of sterility.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Lots / codes

Lot #: 73810, Exp. Date 5/1/2023

Quantity
45 vials
Company
Pharmacy Plus, Inc. dba Vital Care Compounder, Hattiesburg, MS
Distribution
MS only
Initiated
April 13, 2023 · Voluntary: Firm initiated
Classified
April 19, 2023
Reported
April 26, 2023
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.